Global health technology company Philips, a leader in diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, announced plans to invest over $150 million in its U.S. manufacturing and research operations. The move expands the company’s domestic footprint and strengthens its ability to deliver AI-enabled healthcare solutions.
The investment will support facility expansions in Reedsville, Pennsylvania, and Plymouth, Minnesota. The Reedsville site, which manufactures ultrasound systems, will gain 24,000 square feet of manufacturing space and 40,000 square feet of warehouse capacity, creating about 120 skilled manufacturing jobs. In Plymouth, Philips will expand its Image Guided Therapy facility to include a new medtech training center, a project expected to generate over 150 new jobs.
Philips currently invests about $900 million annually in U.S. research and development and employs nearly 17,000 people across 40 locations, serving more than 90% of U.S. hospitals.
“Increasing our manufacturing and R&D capabilities will create jobs and accelerate our ability to deliver better care for more people with innovative AI-enabled solutions,” said Jeff DiLullo, Chief Region Leader, Philips North America.
The new investment comes as health technology companies increase production capacity in the U.S. to meet rising demand for AI-driven tools in diagnostics and treatment, while also addressing supply chain resilience.
